Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
acute hepatic porphyrias
ai hub
ai hub / company / microsoft
ai hub / end user / big company
ai hub / end user / small company
ai hub / sector / health care
ai hub / source data / speech
ai hub / technology / machine learning
ai hub / technology / natural language processing
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
boston
boston blog main
boston top stories
business
business / artificial intelligence
clinical trials
coronavirus
covid-19
cybersecurity
drugs
enterprise
fda
givosiran
life sciences
national blog main
onpattro
patisiran
paul matteis
rna interference
security
stifel financial
tc
What
medicine
6
×
won’t
6
×
company
drug
make
plans
security
ago
aiming
allows
alnylam
announced
antibodies
antibody
approval
away
babies
based
big
billion
birth
brain
breach
breaches
bundle
buy
cause
ceo
certification
clinical
closing
companies
conduct
coronavirus
country
course
covid
crucial
cyber
cybercriminals
Language
unset
Current search:
won’t
×
medicine
×
@pcworld.com
1 year ago
Learn ethical hacking fundamentals with this $40 course bundle
@wired.com
3 years ago
Microsoft Makes a $16 Billion Entry Into Health Care AI
@bgr.com
4 years ago
Crucial coronavirus antibody drug could be ready sooner than expected
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@theverge.com
7 years ago
Zika infection late in pregnancy doesn't cause brain defects, study says
@techcrunch.com
9 years ago
This Cybersecurity Medicine Might Be Tough To Swallow